Peroxiredomin-4 ameliorates lipotoxicity-induced oxidative stress and apoptosis in diabetic cardiomyopathy
Open Access
- 1 September 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 141, 111780
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81803803)
- Chinese Academy of Meteorological Sciences (2019-I2M-1-005)
This publication has 43 references indexed in Scilit:
- Molecular mechanisms of diabetic cardiomyopathyDiabetologia, 2014
- Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse ModelAntioxidants & Redox Signaling, 2013
- Overexpression of Peroxiredoxin 4 Protects Against High-Dose Streptozotocin-Induced Diabetes by Suppressing Oxidative Stress and Cytokines in Transgenic MiceAntioxidants & Redox Signaling, 2010
- Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathyBasic Research in Cardiology, 2007
- Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodentsCardiovascular Diabetology, 2007
- Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathyJournal of Molecular and Cellular Cardiology, 2007
- Role of changes in cardiac metabolism in development of diabetic cardiomyopathyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Proteomics of the HeartCirculation Research, 2006
- Cardiovascular ProteomicsCirculation Research, 2001
- Diabetes, a New Mutation in the MouseScience, 1966